Thu, August 4, 2022
Wed, August 3, 2022
Tue, August 2, 2022
Mon, August 1, 2022
Sun, July 31, 2022
Fri, July 29, 2022

Jonathan Block Maintained (ARQT) at Strong Buy with Increased Target to $50 on, Aug 2nd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-50-on-aug-2nd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jonathan Block of Goldman Sachs, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy with Increased Target from $45 to $50 on, Aug 2nd, 2022.

Jonathan has made no other calls on ARQT in the last 4 months.



There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 0 agree with Jonathan's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jonathan


  • David Lebowitz of "Morgan Stanley" Maintained at Buy with Increased Target to $39 on, Tuesday, June 7th, 2022
  • Uy Ear of "Mizuho" Maintained at Strong Buy with Decreased Target to $57 on, Thursday, April 7th, 2022

Publication Contributing Sources